Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Tardive dyskinesia: Deterioration of symptoms · patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether DOPAMINERGIC DRUGS changes tardive dyskinesia: Deterioration compared with OTHER DRUGS (very low certainty).

1 finding from 1 review

Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 1.17 [0.09, 14.92]
1 study · 13 participants
Very low

Tardive dyskinesia: Deterioration of symptoms · patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether DOPAMINERGIC DRUGS changes tardive dyskinesia: Deterioration compared with PLACEBO (very low certainty).

1 finding from 1 review

Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 1.18 [0.35, 3.99]
2 studies · 37 participants
Very low